Clinical trial
Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
NCT02512003 is registered in ClinicalTrials.gov with REVA Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Lead sponsor
- REVA Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- April 30, 2020
- Enrollment
- 7 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.